IGC PHARMA Announces Positive Interim Results for IGC-AD1 in Reducing[...]
Fitness program for pregnant and postpartum Soldiers enhances readiness[...]
ARUP Laboratories - Associated[...]
Departing Biochemical Geneticist Leaves Legacy of Scientific Discovery[...]
Rutgers, The State University of[...]
Rutgers Health at 10: Interprofessional Education for Better Health[...]
NIH - National Institutes of Health
Experimental NIH malaria monoclonal antibody protective in Malian children
09/24/2021 | Press release | Distributed by Public on 09/24/2021 19:33
Please select the service you want to use:
Smartlinks | Natera Inc. | News | Health | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Public Companies | Biotechnology and Medical Research Companies | Börse Frankfurt | Börse Berlin | Börse München | Börse Stuttgart | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact